Product Launch: Vaccinia Capping System mRNA Guanylyltransferase And mRNA Methyltransferase
Source: Roche CustomBiotech
mRNA Vaccinia Capping System: Proven. Scalable. Tailored to the needs of biopharma companies developing mRNA-based therapies.
Quality by design
Fit-for-purpose & GMP Grade to ensure compliance and minimize your overall risks
Scalable solution
Suitable for various scales of mRNA production from R&D to commercial manufacturing
Robust supply
Enhance business continuity and benefit from greater financial control
Proven expertise
A decade of manufacturing capping enzymes - before, during and beyond the COVID-19 pandemic.
Source from a strong partner for robust supply
Roche CustomBiotech is ready to support your mRNA project